New Study Examines How Cannabis Consumers Determine Potency, How Much Goes Into Joints

A new study published in the journal Addiction has examined the wayThe Guardian joint cannabis consumers determine the potency of cannabis, and how much they use when rolling joints.

Researchers from the Clinical Psychopharmacology Unit of the University College London, and the Department of Psychology from the College of Life and Environmental Sciences, University of Exeter, examined a group of 247 cannabis consumers in the United Kingdom – 152 were considered “recreational” users, consuming cannabis 1–24 days each month, and 95 were recorded as “daily” users, consuming cannabis 25 days or more out of the month.

Read moreNew Study Examines How Cannabis Consumers Determine Potency, How Much Goes Into Joints

Activating Cannabinoid Receptors May Treat Migraines, According to New Study

A new study published by the Journal of Headache and Pain has found that activation of the body’s cannabinoid receptorsmigraine – something done naturally by cannabis – may treat migraines.

The study, titled Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model, used male rats to study the effects of a cannabinoid receptor agonist (an activator) on the treatment of severe migraines.

Read moreActivating Cannabinoid Receptors May Treat Migraines, According to New Study

Study: Opioid Overdose Deaths Drop As Much As 50% in States Where Medical Cannabis is Legalized

A new study published online yesterday in the Journal of the American Medical Association Internal Medicine has found states that have legalized medical cannabis have seen a drastic reduction of opioid overdose mortality rates.pills

Researchers from the Philadelphia Veterans Affairs Medical Center, the University of Pennsylvania, Montefiore Medical Center/Albert Einstein College of Medicine and Johns Hopkins Bloomberg School of Public Health examined the prescription painkiller overdose death rates of all 50 states between 1999 and 2010, using data from the U.S. Centers for Disease Control and Prevention.

Read moreStudy: Opioid Overdose Deaths Drop As Much As 50% in States Where Medical Cannabis is Legalized

New Study Finds Cannabis May Help Combat Osteoporosis in Men With Prostate Disease

A new study has found evidence that cannabis may help treat osteoporosis, specifically in men suffering from prostate disease.osteoporosis

According to researchers from Konkuk University, in Seoul, Republic of Korea, a substantial portion of men with prostatic disease have an increased risk of bone loss, but activating cannabinoid receptors can help combat these effects. Scientists induced prostatic hyperplasia (enlargement of the prostate gland) in rats and administered a cannabinoid agonist. The enhanced cannabinoid receptor expression caused an upregulation of osteoblastogenesis, or an increase in bone growth, while inhibiting the prostatic hyperplasia.

Read moreNew Study Finds Cannabis May Help Combat Osteoporosis in Men With Prostate Disease

Study: Cannabis Use Doesn’t Worsen Symptoms of Schizophrenia

A study published this month by the journal Schizophrenia Bulletin has found that cannabis use doesn’t negatively impact the symptoms ofBrain schizophrenia in those with the condition. Although this may come as no surprise to many, it helps to combat the prohibitionist argument that cannabis use is a detriment to those with schizophrenia.

“There are inconsistencies in findings as to whether cannabis use has a negative impact on clinical outcomes for people with established psychosis”, says professor Christine Barrowclough, PhD, who led the study. Due to these inconsistencies, researchers at the University of Manchester and University of Lancaster investigated “the relationship between cannabis use and clinical outcome, including whether change in cannabis use affects psychotic symptoms, affective symptoms, functioning and psychotic relapse in a sample of people in early psychosis with comorbid cannabis abuse or dependence.”

Read moreStudy: Cannabis Use Doesn’t Worsen Symptoms of Schizophrenia

Cannabis May Protect Against Ischemic Cardiomyopathy

An interesting new study published in this month’smedcannabis issue of the journal Basic Research in Cardiology has found that the endocannabinoid system plays a key role in protecting the body in the early development of ischemic cardiomyopathy, indicating that cannabis, which regulates and activates the body’s cannabinoid receptors, may provide a potential treatment option for the condition.

Ischemic cardiomyopathy, which is inadequate oxygen delivery to the myocardium (the heart muscle), is most commonly caused by coronary artery disease and can lead to heart failure.

Read moreCannabis May Protect Against Ischemic Cardiomyopathy

Study: Cannabis May Treat Bacterial Translocation

Bacterial translocation, which is the migration of bacteria from the intestinal lumen to mesenteric lymph nodes (according to Medscape)cannabisisnotpot, is increased in those with cirrhosis, and can lead to spontaneous bacterial peritonitis (SBP). SBP is a condition which symptoms include fevers, chills and vomiting. According to a new study published by the Journal of Hepatology, cannabinoid receptor agonists – something which cannabis naturally is – may treat bacterial translocation and other “relevant abnormalities”.

For the study, researchers at the National Yang-Ming University School of Medicine, and Chang Gung University’s Graduate Institute of Traditional Chinese Medicine (both in Taiwan), gave cannabinoid receptor agonists to “thioacetamide (TAA)- and common bile duct ligation (BDL)-cirrhotic rats with ascites for 2-weeks and various measurement were performed.”

Read moreStudy: Cannabis May Treat Bacterial Translocation

Long-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study

A study published last week by the journal European Neurology has found that the long-term use of Sativex, a spray made from the cannabis plant (one part THC, one part CBD), is effectivesativex1 in treating multiple sclerosis spasticity.

According to researchers, the study’s objective was to “provide long-term data on clinical outcomes, tolerability, quality of life and treatment satisfaction for MSS [multiple sclerosis spasticity] patients receiving nabiximols [Sativex] in routine care.”

Read moreLong-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study

Neuropsychopharmacology Journal Publishes Study Showing Cannabinoids Can Treat PTSD

A new study e-published ahead of print by Neuropsychopharmacology, the official publication of the American College of mmjbuddingNeuropsychopharmacology, has determined that cannabinoids can help treat, or even prevent, the effects of PTSD.

Scientists from the Department of Psychology of the University of Haifa in Israel examined rat models suffering from shock-induced PTSD (post-traumatic stress disorder). The rats were each given an injection of either a cannabinoid receptor agonist (a substance that mimics the effects of cannabis) or a control placebo 2 hours after the shock.

Read moreNeuropsychopharmacology Journal Publishes Study Showing Cannabinoids Can Treat PTSD

New Study: Despite Perceived Risks, Dabbing is Safe

A new study published in the most recent issue of the journal Addictive Behavior has found that dabbing – the process of consuming cannabis extracts suchdabs as butane hash oil – is safe and causes no more accidents than cannabis in any other form, despite consumers perceiving there being a greater risk.

According to the study; “A new method for administering cannabinoids, called butane hash oil (“dabs”), is gaining popularity among marijuana users. Despite press reports that suggest that “dabbing” is riskier than smoking flower cannabis, no data address whether dabs users experience more problems from use than those who prefer flower cannabis.”

Read moreNew Study: Despite Perceived Risks, Dabbing is Safe